Sanofi expects to extend its leadership in Emerging Markets, which are expected to account for 38% to 40% of its sales in 2015 compared to 29% in 2010. This objective implies double-digit sales growth in Emerging Markets over 2012-2015.
SNY defines emerging markets as everywhere other than the U.S., Canada, Western Europe, Japan, Australia, and New Zealand.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”